We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Stakeholders Urge FDA to Expand Guidance on Enrichment Trials
Stakeholders Urge FDA to Expand Guidance on Enrichment Trials
March 22, 2013
Drugmakers and industry organizations are asking the FDA to expand the scope of a draft guidance on enrichment trial designs released at the end of last year.